Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Dow
Merck
Moodys
Mallinckrodt
Colorcon
McKesson

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR GALLIUM GA-68 PSMA-11


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Gallium Ga-68 Psma-11

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00002543 ↗ Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors Completed National Cancer Institute (NCI) Phase 1 1995-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002543 ↗ Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors Completed Medical College of Wisconsin Phase 1 1995-02-01 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: : Phase I trial to study the effectiveness of gallium nitrate in young patients who have malignant brain tumors, neuroblastoma, rhabdomyosarcoma, non-Hodgkin's lymphoma, or refractory solid tumor.
NCT00002578 ↗ Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma Completed National Cancer Institute (NCI) Phase 2 1994-08-01 RATIONALE: Chemotherapy uses different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of gallium nitrate in treating patients with AIDS-related non-Hodgkin's lymphoma.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Gallium Ga-68 Psma-11

Condition Name

Condition Name for Gallium Ga-68 Psma-11
Intervention Trials
Prostate Cancer 19
Lymphoma 12
Stage IVB Prostate Cancer AJCC v8 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Gallium Ga-68 Psma-11
Intervention Trials
Prostatic Neoplasms 38
Neuroendocrine Tumors 18
Carcinoma 17
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Gallium Ga-68 Psma-11

Trials by Country

Trials by Country for Gallium Ga-68 Psma-11
Location Trials
United States 171
Italy 21
Canada 7
France 6
China 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Gallium Ga-68 Psma-11
Location Trials
California 39
Texas 15
Minnesota 9
Iowa 9
Maryland 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Gallium Ga-68 Psma-11

Clinical Trial Phase

Clinical Trial Phase for Gallium Ga-68 Psma-11
Clinical Trial Phase Trials
Phase 4 1
Phase 3 11
Phase 2/Phase 3 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Gallium Ga-68 Psma-11
Clinical Trial Phase Trials
Recruiting 44
Completed 34
Terminated 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Gallium Ga-68 Psma-11

Sponsor Name

Sponsor Name for Gallium Ga-68 Psma-11
Sponsor Trials
National Cancer Institute (NCI) 29
M.D. Anderson Cancer Center 11
University of California, San Francisco 11
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Gallium Ga-68 Psma-11
Sponsor Trials
Other 155
NIH 33
Industry 28
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Express Scripts
Moodys
Medtronic
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.